Skip to main content
padlock icon - secure page this page is secure
The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.

Publisher: Spandidos Publications

More about this publication?
Volume 7, Number 5, 1 November 1995

Articles

THE FIRST INTRON OF HUMAN H-RAS IS REGULATED BY P53 - MEDIATION OF SPECIFIC ACTIVATION BY A P53-BINDING ELEMENT
pp. 1021-1028(8)
Authors: ZHANG, W; RANDHAWA, GS; GAU, JP; SHAY, JW; DEISSEROTH, AB

Favourites:
ADD

SPECIFIC RECOGNITION OF A TRANSCRIPTIONAL ELEMENT WITHIN THE HUMAN H-RAS PROTOONCOGENE BY THE P53 TUMOR-SUPPRESSOR
pp. 1029-1034(6)
Authors: SPANDIDOS, DA; ZOUMPOURLIS, V; ZACHOS, G; TOAS, SH; HALAZONETIS, TD

Favourites:
ADD

BINDING OF WILD-TYPE AND MUTANT FORMS OF P53 PROTEIN FROM HUMAN TUMORS TO A SPECIFIC DNA-SEQUENCE OF THE FIRST INTRON OF THE H-RAS ONCOGENE
pp. 1035-1041(7)
Authors: ZOUMPOURLIS, V; ZACHOS, G; HALAZONETIS, TD; ERGAZAKI, M; SPANDIDOS, DA

Favourites:
ADD

MOLECULAR ABNORMALITIES OF MDM-2 IN HUMAN SARCOMAS
pp. 1043-1048(6)
Authors: BUESORAMOS, CE; YANG, Y; MANSHOURI, T; FELTZ, L; AYALA, A; GLASSMAN, AB; ALBITAR, M

Favourites:
ADD

DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
pp. 1049-1056(8)
Authors: RAGNHAMMAR, P; FRODIN, JE; HJELM, AL; FAGERBERG, J; WERSALL, P; LINDEMALM, C; NILSSON, B; FOX, K; MAGNUSSON, I; EWERTH, S; THOR, K; SECHER, E; MELLSTEDT, H

Favourites:
ADD
Favourites:
ADD

ACTIVIN AND ACTIVIN RECEPTORS IN A RAT OSTEOGENIC-SARCOMA CELL-LINE, UMR-106
pp. 1061-1065(5)
Authors: YING, SY; ZHANG, Z; HUANG, G; BATRES, Y

Favourites:
ADD

IN-VIVO EFFECT OF THE COMBINATION OF TNF AND ADRIAMYCIN AGAINST A HUMAN BREAST CELL-LINE EXPRESSING THE MDR-PHENOTYPE
pp. 1067-1072(6)
Authors: ZYAD, A; CAI, ZZ; MORIZET, J; LEGRES, LG; BENARD, J; CHOUAIB, S

Favourites:
ADD

INDUCTION OF TUMORIGENICITY BY GALECTIN-3 IN A NONTUMORIGENIC HUMAN BREAST-CARCINOMA CELL-LINE
pp. 1079-1087(9)
Authors: NANGIAMAKKER, P; THOMPSON, E; HOGAN, C; OCHIENG, J; RAZ, A

Favourites:
ADD

STEROID-HORMONE PRODUCTION AND RECEPTORS IN RELATION TO KI-67, P53, S-PHASE FRACTION AND PLOIDY IN EPITHELIAL OVARIAN-TUMORS
pp. 1095-1102(8)
Authors: RIDDERHEIM, M; TRIBUKAIT, B; STENDAHL, U; BACKSTROM, T; CAJANDER, S

Favourites:
ADD

MUTATIONAL ANALYSIS OF THE TUMOR-SUPPRESSOR GENE WT1 - DETECTION OF A NOVEL HOMOZYGOUS POINT MUTATION IN SPORADIC UNILATERAL WILMS-TUMOR
pp. 1103-1107(5)
Authors: KOSTERS, R; ADAMS, V; HASSAM, S; SCHAFER, R; SCHMID, M; MOOS, R; BRINER, J

Favourites:
ADD

A ROLE FOR HISTAMINE IN HUMAN-MALIGNANT GLIOMA-CELLS
pp. 1109-1115(7)
Authors: HIROHATA, M; SASAGURI, Y; SHIGEMORI, M; MARUIWA, H; MORIMATSU, M

Favourites:
ADD

INTERLEUKIN-4 INHIBITS LAK AND INITIAL PHASE TIL ACTIVITY VIA INTERLEUKIN-2 RECEPTOR
pp. 1117-1121(5)
Authors: TSUNODA, T; TANIMURA, H; YAMAUE, H; IWAHASHI, M; TANI, M; TAMAI, M; NOGUCHI, K; MIZOBATA, S; ARII, K

Favourites:
ADD

IDENTIFICATION OF GENES OVEREXPRESSED IN THE SQCC/Y1 HUMAN BUCCAL CARCINOMA CELL-LINE USING THE DIFFERENTIAL DISPLAY METHOD
pp. 1123-1128(6)
Authors: SUNDQVIST, K; IOTSOVA, V; ZIAIE, SV; WIMAN, KG; HOOG, C; GRAFSTROM, RC

Favourites:
ADD

ADJUVANT CHEMOENDOCRINE THERAPY FOR EARLY BREAST-CANCER - IS IT WORTHWHILE - (REVIEW)
pp. 1129-1137(9)
Authors: PERRONE, F; DEPLACIDO, S; GALLO, C; CARLOMAGNO, C; LAURIA, R; BIANCO, AR

Favourites:
ADD

PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE-ACTIVITY AND BIOLOGICAL CHARACTERISTICS OF BREAST-CANCER
pp. 1139-1144(6)
Authors: TAKAHASHI, H; UCHINO, J; OGITA, M; SASAKI, F; HATA, Y; YOSHIMOTO, M; AKASAKA, Y; NAKANISHI, Y; SAWADA, Y

Favourites:
ADD

EXPRESSION AND STRUCTURE OF HOX GENES IN WILMS-TUMOR
pp. 1145-1150(6)
Authors: CILLO, C; WILMORE, HP; BARBA, P; BROWN, KW

Favourites:
ADD

HEAD AND NECK EXTRANODAL NON-HODGKIN-LYMPHOMA - RADIATION-THERAPY AND CHEMOTHERAPY
pp. 1151-1157(7)
Authors: DONATO, V; VENTRONI, G; CARDELLO, P; IACARI, W; DESANCTIS, V; BANELLI, E; TOMBOLINI, V; ENRICI, RM

Favourites:
ADD

ALLELE LOSS IN HUMAN GASTRIC CARCINOMAS - RELATION TO TUMOR PROGRESSION AND DIFFERENTIATION
pp. 1159-1166(8)
Authors: SERUCA, R; CONSTANCIA, M; DOSSANTOS, NR; DAVID, L; QUEIMADO, L; CARVALHO, F; CARNEIRO, F

Favourites:
ADD

IN-VIVO EFFECT OF SOMATOSTATIN ANALOG, LANREOTIDE, AND/OR GRP ANTAGONIST, BIM-26226, ON THE GROWTH OF COLON-CANCER PERITONEAL CARCINOMATOSIS IN THE RAT
pp. 1167-1173(7)
Authors: GOUYON, BA; REYLDESMARS, F; LEROMANCER, M; PIGEON, C; LEWIN, MJM; LEHY, T

Favourites:
ADD

A PHASE-II STUDY TESTING A COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND VINDESINE AS 2ND LINE TREATMENT FOR PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
pp. 1175-1178(4)
Authors: SCULIER, JP; BUREAU, G; THIRIAUX, J; LECOMTE, J; RECLOUX, P; BERCHIER, MC; KROLL, F; BROHEE, D; MOMMEN, P; PAESMANS, M; SERGYSELS, R; KLASTERSKY, J

Favourites:
ADD

CROSS-SENSITIVITY TO X-RADIATION AND TYPE-I AND TYPE-II DNA TOPOISOMERASE INHIBITORS IN A RANGE OF HUMAN AND RODENT CELL-LINES
pp. 1179-1184(6)
Authors: NG, CE; BUSSEY, AM; MACDONALD, HA; HELLER, DP; WILKINS, DE; RAAPHORST, GP

Favourites:
ADD

THE ROLE OF A DROSOPHILA REPLICATION RELATED ELEMENT IN DRAS2 ONCOGENE REGULATION
pp. 1185-1191(7)
Authors: LIGHTFOOT, K; TAI, A; SEGEV, O

Favourites:
ADD
Favourites:
ADD

INHIBITION OF DRAS2/ROP EXPRESSION IN XENOPUS OOCYTES BY DROSOPHILA NUCLEAR EXTRACT
pp. 1203-1212(10)
Authors: DUARTE, RAB; STEIN, L; FABIAN, BC; SEGEV, O

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more